Conmed (CNMD) Total Non-Current Liabilities (2010 - 2026)

Conmed (CNMD) has reported Total Non-Current Liabilities for 17 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Non-Current Liabilities fell 3.91% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (down 3.91% YoY), and the FY2025 full-year result was $1.2 billion, down 2.26% from the prior year.
• Total Non-Current Liabilities slipped to $1.2 billion in Q2 2026 per CNMD's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $1.4 billion in Q2 2023 and bottomed at $954.4 million in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
• The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities jumped 44.76% in 2023, then decreased 7.5% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $1.3 billion in 2022, then dropped by 0.27% to $1.3 billion in 2023, then fell by 6.51% to $1.3 billion in 2024, then declined by 2.26% to $1.2 billion in 2025, then slipped by 2.59% to $1.2 billion in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.2 billion, $1.2 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.